Description
Buy Tirzepatide 20mg (R&D Only) Peptides EU
Tirzepatide 20mg is a premium quality lyophilized research peptide designed for advanced laboratory investigations into metabolic disorders, obesity pathophysiology, and glucose regulation mechanisms. As the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications, this compound represents a significant advancement in metabolic research tools. Buy Tirzepatide 20mg (R&D Only) Peptides EU
For researchers conducting studies on GLP-1 research peptides EU applications, Tirzepatide offers unique dual-receptor activation properties that distinguish it from single-agonist compounds. This 20mg format provides optimal quantity for extended research protocols while maintaining cost effectiveness for laboratory budgets. Buy Tirzepatide 20mg (R&D Only) Peptides EU
All products are strictly for research use only and comply with EU laboratory standards. Visit our homepage at euresearchpeptides.com to explore our comprehensive range of buy peptides EU products.
Purity Specifications with HPLC/MS Data
Every batch of Tirzepatide 20mg undergoes rigorous analytical testing to ensure research grade quality:
| Test Parameter | Specification | Method |
|---|---|---|
| Peptide Purity | ≥99.0% | HPLC (214nm) |
| Single Largest Impurity | ≤0.5% | HPLC |
| Total Impurities | ≤1.0% | HPLC |
| Mass Confirmation | 4813.45 ± 1.0 Da | ESI-MS |
| Acetate Content | ≤12.0% | Ion Chromatography |
| Water Content (Karl Fischer) | ≤8.0% | Titration |
| Bacterial Endotoxins | <1.0 EU/mg | LAL Test |
| Sterility | Negative | USP Method |
Each shipment includes a Certificate of Analysis with full HPLC chromatogram and mass spectrometry data. This documentation supports publication requirements for peptides for research France and laboratory peptides Netherlands institutions.
Solubility Profile
| Solvent | Solubility | Recommendation |
|---|---|---|
| Sterile Water for Injection | 10-20 mg/mL | Optimal for research |
| Bacteriostatic Water | 10-20 mg/mL | Preferred for multi-use |
| Sterile Saline (0.9% NaCl) | 8-15 mg/mL | Acceptable |
| PBS (pH 7.4) | 10-20 mg/mL | Recommended for in vivo |
| DMSO | >30 mg/mL | for in vitro only |
Tirzepatide demonstrates excellent solubility in aqueous solutions. For best results, allow lyophilized powder to reach room temperature before reconstitution. Add diluent slowly down the inner wall of the vial and swirl gently until complete dissolution. Do not vortex or shake vigorously as this may compromise peptide integrity.
Stability Data
| Storage Condition | Lyophilized | Reconstituted Solution |
|---|---|---|
| -80°C | 36 months | Not recommended |
| -20°C (freezer) | 24 months | Not recommended |
| 2-8°C (refrigerated) | 12 months | 30-60 days |
| 15-25°C (room temp) | 30 days | 8-12 hours |
| 37°C (incubation) | Not recommended | 4-6 hours |
Important Stability Notes
-
Use a manual defrost freezer and avoid repeated freeze-thaw cycles
-
After reconstitution, refrigerate immediately at 2-8°C
-
Store lyophilized peptide in original packaging protected from light
-
Do not store reconstituted solutions in frost-free freezers
-
Discard if solution appears cloudy or contains particulate matter
Recommended Storage Conditions
Lyophilized Powder
Store at -20°C ± 5°C in a manual defrost freezer. Protect from light and moisture. Under these conditions, the product remains stable for 24 months from date of manufacture.
Reconstituted Solution
After reconstitution in sterile water or bacteriostatic water, store at 2-8°C (refrigerated). Use within 60 days for optimal research outcomes. For BPC-157 Europe and other peptide research applications, always label vials with reconstitution date and concentration.
Shipping Conditions
Products ship in insulated packaging with refrigerant packs to maintain cold chain integrity during transit to all EU destinations including Germany, France, Netherlands, Spain, and Italy.
Known Research Applications with Citations
Obesity and Body Weight Regulation Research
Tirzepatide has demonstrated superior efficacy in weight loss research compared to single GLP-1 receptor agonists. Studies indicate that its anti-obesity effect operates primarily through food intake reduction mechanisms, with additional direct effects on adipose tissue metabolism.
Key research findings include:
-
Significant body weight reduction in diet-induced obesity mouse models
-
Dose-dependent improvements in metabolic parameters including glycemic control
-
Effects on white and brown adipose tissue beyond calorie restriction alone
Glucose Metabolism and Diabetes Research
As a dual GIP/GLP-1 receptor agonist, Tirzepatide enhances insulin secretion, suppresses glucagon release, and improves insulin sensitivity. Research applications include:
-
Glycemic control mechanism studies
-
Beta cell function investigations
-
Insulin resistance pathophysiology
Adipose Tissue Biology
Recent research has revealed that Tirzepatide exerts distinct effects on different adipose tissue depots:
-
Brown adipose tissue activation and thermogenic gene upregulation
-
White adipose tissue lipid metabolism modulation
-
Reduced inflammatory status in obese research models
Leptin Receptor Signaling Pathways
Studies have demonstrated that Tirzepatide’s weight reduction effects involve leptin receptor signaling mechanisms, providing insights into integrated metabolic regulation.
Emerging Research Areas
Bibliometric analysis of global Tirzepatide research identifies emerging themes including:
-
Real-world evidence studies
-
Metabolic dysfunction-associated steatotic liver disease (MASLD)
-
Long-term safety profiling
-
Cost effectiveness research
Molecular Mechanism of Action
Tirzepatide is a 39-amino acid linear peptide engineered as a GIP analogue with selective agonist activity at both GIP and GLP-1 receptors. While it binds with comparable affinity to GIP receptors as native GIP, its affinity for GLP-1 receptors is approximately five-fold higher than that of native GLP-1.
The compound incorporates a C20 fatty diacid moiety that promotes extended half-life by binding to albumin, increasing therapeutic sensitivity. This structural modification distinguishes Tirzepatide from other research SARMs and peptide compounds in metabolic research.
Activation of the adenylyl cyclase-cAMP-protein kinase A (PKA) pathway stimulates the Krebs cycle and glycolysis, leading to increased intracellular ATP levels. This triggers plasma membrane ATP-sensitive K+ channel closure in pancreatic beta cells, causing depolarization and subsequent insulin exocytosis.
Proper Handling Protocols
Required Safety Equipment
-
Powder-free nitrile gloves
-
Safety goggles
-
Laboratory coat
-
Biosafety cabinet for reconstitution
-
Sharps container
Handling Precautions for Research Chemicals EU Compliant
All research chemicals EU compliant protocols require:
-
Never pipette by mouth
-
Avoid skin and eye contact
-
Work in well-ventilated area or fume hood
-
Decontaminate spills with appropriate disinfectant
-
Wash hands thoroughly after handling
Disposal Guidelines
-
Unused peptide: chemical waste disposal per local regulations
-
Contaminated materials: autoclave before disposal
-
Empty vials: decontaminate before discarding
Reconstitution Guidelines
For high purity peptides Germany and laboratory peptides Netherlands research standards, follow these protocols:
Step 1: Preparation
Remove Tirzepatide vial from freezer and allow to reach room temperature (15-20 minutes). This prevents condensation inside the vial.
Step 2: Calculate Volume
Target Concentration (mg/mL) = Peptide Mass (mg) ÷ Diluent Volume (mL)
Examples for 20mg vial:
-
For 10 mg/mL: Add 2.0 mL diluent
-
For 5 mg/mL: Add 4.0 mL diluent
-
For 2 mg/mL: Add 10.0 mL diluent
Step 3: Sterile Technique
Wipe rubber stopper with alcohol prep pad. Using sterile syringe, draw calculated volume of sterile water or bacteriostatic water.
Step 4: Reconstitution
Inject diluent slowly down the inner glass wall of the vial. Do not inject directly onto the lyophilized cake. Swirl gently until complete dissolution. Do not shake.
Step 5: Post-Reconstitution
Refrigerate immediately at 2-8°C. Use within 60 days. Document concentration and date on vial label.
For research requiring nasal spray administration, refer to our Research Spray Add-on Kit which includes bacteriostatic water, sterile vials, and nasal spray bottles.
Safety Considerations
Tirzepatide is a potent dual receptor agonist and must be handled with appropriate precautions:
Potential Research Hazards
-
May cause gastrointestinal effects in research models
-
Pancreatic and thyroid monitoring recommended in long-term studies
-
Use appropriate personal protective equipment at all times
Not for Human Use
This product is supplied for laboratory research use only. Not for human consumption, veterinary use, or clinical applications. Tirzepatide is a prescription medication for human use, and this research grade product does not meet pharmaceutical standards for human administration.
Regulatory Compliance
As a peptide supplier Spain and EU based distributor, we comply with all applicable regulations regarding research chemical distribution. Products are for qualified researchers affiliated with recognized institutions only.
Why Choose Euresearchpeptides.com
As a premium UE-based online retailer, we provide:
-
EU Warehousing – Fast shipping across Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, Denmark, and all EU member states
-
Verified Purity – Every batch includes Certificate of Analysis with HPLC/MS data showing ≥99% purity
-
EU Compliance – Full adherence to research chemicals EU compliant regulations
-
Cold Chain Integrity – Temperature controlled shipping to preserve peptide stability
-
Expert Support – Technical assistance for reconstitution and protocol questions
-
Complete Research Solutions – From BPC-157 Europe to GLP-1 research peptides EU, we supply comprehensive research tools
SEO FAQ Section – High Commercial Intent
Q1: Where can I buy Tirzepatide 20mg for research in Europe?
You can purchase Tirzepatide 20mg from euresearchpeptides.com, a trusted buy peptides EU supplier with warehouse operations across Europe. We offer fast shipping to Germany, France, Netherlands, Spain, and all EU countries. [Shop now]
Q2: What is the purity of your Tirzepatide 20mg?
Our Tirzepatide 20mg is verified at ≥99% purity by HPLC/MS analysis. Each shipment includes a Certificate of Analysis with full chromatographic data, meeting high purity peptides Germany research standards. [View COA]
Q3: How do I reconstitute Tirzepatide 20mg?
Reconstitute by adding calculated volume of sterile water or bacteriostatic water slowly down the vial wall. Swirl gently to dissolve. Do not shake. For detailed peptides for research France protocols, see our reconstitution guide. [Get guide]
Q4: What is the stability of reconstituted Tirzepatide?
When stored at 2-8°C after reconstitution, Tirzepatide remains stable for 30-60 days. For laboratory peptides Netherlands research, always refrigerate and avoid freeze-thaw cycles. [Storage info]
Q5: Do you ship to my country in Europe?
We ship to all EU member countries as a leading peptide supplier Spain and EU distributor including Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, Denmark, and more. [Check shipping]
Q6: What are the research applications for Tirzepatide?
Tirzepatide is used in obesity research, glucose metabolism studies, adipose tissue biology, and metabolic disorder investigations. For research SARMs and peptide research applications, see our application guide. [Learn more]
Q7: Is this product for human use?
No. This product is strictly for laboratory research use only. For research chemicals EU compliant standards, this product is not for human consumption or clinical use. [Terms]
Q8: How should I store Tirzepatide 20mg?
Store lyophilized powder at -20°C. After reconstitution for GLP-1 research peptides EU studies, store at 2-8°C and use within 60 days. [Storage protocol]
Q9: What is the molecular weight of Tirzepatide?
Tirzepatide has a molecular weight of 4,813.45 g/mol with molecular formula C₂₂₅H₃₄₈N₄₈O₆₈. For peptide synthesis Europe research, full characterization data is available. [Specs]
Q10: What is included with my order?
Each order includes one 20mg vial of Tirzepatide lyophilized powder, Certificate of Analysis, and product documentation. For complete buy peptides EU research setup, consider our Research Spray Add-on Kit. [View kit]
Q11: How does Tirzepatide compare to Semaglutide for research?
Tirzepatide is a dual GIP/GLP-1 receptor agonist while Semaglutide is a selective GLP-1 receptor agonist. Research indicates Tirzepatide may produce greater weight reduction effects in comparative studies for BPC-157 Europe and metabolic research. [Compare]
Q12: What is the mechanism of action for Tirzepatide?
Tirzepatide activates both GIP and GLP-1 receptors, enhancing insulin secretion, reducing appetite, slowing gastric emptying, and promoting satiety through central and peripheral mechanisms. For laboratory peptides Netherlands research, full mechanism data available. [Mechanism]






Reviews
There are no reviews yet.